HLHuafeng Luo

Huafeng Luo

*This is an algorithmically generated author record based on publicly available information.

Huafeng Luo has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Chunwei Yang

    Guangdong Qifang Pharmaceutical Co., Ltd., Guangzhou 510075, China

    2 shared publications
  • Jie Wang

    Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Tuberculosis Research Institute, the 8th Medical Center, Chinese PLA General Hospital, Beijing, China

    2 shared publications
  • Jinying Song

    Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China

    2 shared publications
  • Jun Liu

    Guangdong Qifang Pharmaceutical Co., Ltd, Guangzhou, China

    2 shared publications
  • Lan Wang

    Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, 100091 Beijing, China

    2 shared publications
  • Shibing Chen

    Army Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, The 8th Medical Centre of Chinese PLA General Hospital, Beijing 100091, China

    2 shared publications

Latest Publications

  • Open Access

    Chinese Traditional Medicine NiuBeiXiaoHe (NBXH) Extracts Have the Function of Antituberculosis and Immune Recovery in BALB/c Mice

    by Yan Liang, Wenping Gong, Xiaomei Wang, Junxian Zhang, Yanbo Ling, Jinying Song, Lan Wang, Xiao Liu, Jie Wang, Yourong Yang, et al.

    Background. The Traditional Chinese Medicine NiuBeiXiaoHe (NBXH) is a valid antituberculosis (TB) prescription from the experience of clinical practice. However, the mechanism of NBXH extracts' immunotherapy has been poorly understood. Herein, the immunotherapeutic efficacy and the differentially expressed (DE) genes of NBXH extracts were evaluated and identified in BALB/c mice. Methods. The total RNA was extracted from peripheral blood mononuclear cells, and the DE genes were identified by gene chip. The enrichment and signaling pathway analyses were performed using Gene Ontology (GO) and KEGG database. Results. It was shown that the treatment of NBXH extracts (high dose) significantly reduced mycobacteria loads and histopathological lesions in mice infected by Mycobacterium tuberculosis and resulted in 3,454 DE upregulated genes and 3,594 downregulated DE genes. Furthermore, NBXH extracts killed mycobacteria by inhibiting the supply of necessary ingredients for their growth and proliferation. They restored the disordered immune microenvironments by up- or downregulating immune and inflammation-related pathways. Conclusions. Taken together, NBXH extracts not only efficiently decreased the mycobacteria loads but also balanced the immune disorders in mice. These new findings provide a fresh perspective for elucidating the immunotherapeutic mechanism of NBXH extracts and pointed out the direction for improving the treatment efficacy of NBXH extracts.


  • Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models

    by Yan Liang, Xiaomei Wang, Jinying Song, Lan Wang, Dan Chen, Yourong Yang, Xuejuan Bai, Jie Wang, Yingchang Shi, Shibing Chen, et al.